SEC 13F Intelligence

Altium Capital Management LLC / LRMR

Altium Capital Management LLC’s Larimar Therapeutics Inc Position

Does Altium Capital Management LLC own Larimar Therapeutics Inc (LRMR)? Not currently — the last reported position was 273.2K shares worth $587,389 in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$587,389
Q1 2025
Shares
273.2K
% of Portfolio
+1.42%
Quarters Held
8
position exited

Position History LRMR

Reported value by quarter
Q4 ’20: $2MQ4 ’20Q1 ’21: $1MQ1 ’21Q3 ’22: $1MQ3 ’22Q1 ’24: $5MQ1 ’24Q2 ’24: $5MQ2 ’24Q3 ’24: $5MQ3 ’24Q4 ’24: $2MQ4 ’24Q1 ’25: $587,389Q1 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2025273.2K$587,389+1.42%
Q4 2024505.0K$2M+0.55%
Q3 2024693.0K$5M+1.34%
Q2 2024693.0K$5M+2.05%
Q1 2024695.0K$5M+2.09%
Q3 2022320.0K$1M+0.38%
Q1 202193.3K$1M+0.38%
Q4 202093.3K$2M+0.75%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of LRMR.